These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2316744)

  • 1. MAOIs and Ménière's syndrome.
    Mattes JA
    Am J Psychiatry; 1990 Apr; 147(4):534. PubMed ID: 2316744
    [No Abstract]   [Full Text] [Related]  

  • 2. The behavioral toxicity of monoamine oxidase-inhibiting antidepressants.
    Murphy DL
    Adv Pharmacol Chemother; 1977; 14():71-105. PubMed ID: 18913
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs.
    Blackwell B; Marley E; Price J; Taylor D
    Br J Psychiatry; 1967 Apr; 113(497):349-65. PubMed ID: 6034391
    [No Abstract]   [Full Text] [Related]  

  • 4. [Irreversible, non-selective monoamine oxidase inhibitors].
    Castberg I; Spigset O
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):746-8. PubMed ID: 19373300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
    Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K
    J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors.
    Fallon B; Foote B; Walsh BT; Roose SP
    J Clin Psychiatry; 1988 Apr; 49(4):163-5. PubMed ID: 3281932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of pethidine and morphine in the presence of monoamine oxidase inhibitors.
    Evans-Prosser CD
    Br J Anaesth; 1968 Apr; 40(4):279-82. PubMed ID: 5654977
    [No Abstract]   [Full Text] [Related]  

  • 8. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report.
    Safferman AZ; Masiar SJ
    Ann Pharmacother; 1992 Mar; 26(3):337-8. PubMed ID: 1554951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three cases of female anorgasmia associated with MAOIs.
    Lesko LM; Stotland NL; Segraves RT
    Am J Psychiatry; 1982 Oct; 139(10):1353-4. PubMed ID: 7124995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of MAO inhibition.
    Baxter LR
    J Clin Psychiatry; 1984 May; 45(5):234. PubMed ID: 6725215
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS].
    HORNYKIEWICZ O
    Wien Klin Wochenschr; 1964 Apr; 76():289-93. PubMed ID: 14223504
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible Cerebral Vasoconstriction Syndrome and Monoamine Oxidase Inhibitors.
    Durmuş B; Osse RJ; Emmer B; van Kooten F
    Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 27922229
    [No Abstract]   [Full Text] [Related]  

  • 15. Stroke resulting from a rapid switch from phenelzine to tranylcypromine.
    Mattes JA
    J Clin Psychiatry; 1998 Jul; 59(7):382. PubMed ID: 9714269
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monoamine oxidase inhibitors as pharmaceutical agents].
    Cherkes OI; Chekman IS
    Farm Zh; 1969; 24(1):10-4. PubMed ID: 4389639
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuromuscular effects of monoamine oxidase inhibitors.
    Lieberman JA; Kane JM; Reife R
    Adv Neurol; 1986; 43():231-49. PubMed ID: 3511628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS.
    GOLDBERG LI
    JAMA; 1964 Nov; 190():456-62. PubMed ID: 14197995
    [No Abstract]   [Full Text] [Related]  

  • 20. Classics in Chemical Neuroscience: Selegiline, Isocarboxazid, Phenelzine, and Tranylcypromine.
    Hoffman GR; Olson MG; Schoffstall AM; Estévez RF; Van den Eynde V; Gillman PK; Stabio ME
    ACS Chem Neurosci; 2023 Dec; 14(23):4064-4075. PubMed ID: 37966854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.